時間 | 講題 | 主講人/單位 | |
8:30~9:00 | 報到及領取講義 | ||
9:00~9:10
|
Welcome & Opening Remarks |
郭明良院長(Ming Liang, Kuo) 國立台灣大學生命科學院 |
|
王玉杯理事長(Yu-pei Wang) 中華民國製藥發展協會 |
|||
9:10~10:40 | Developing new drugs with guidance from the new global USFDA. |
Alan Liss, Ph. D. Senior Advisor, Development at Original BioMedicals, USFDA, Director, MCM AT (Retired) |
|
10:40~11:00 | Coffee Break | ||
11:00~12:30 | New Emerging Technologies in Drug Development |
W.C. Chiang, Ph.D. General Manager at JoWin Biopharma Inc. |
|
12:30~13:30 | Lunch | ||
13:30~14:30 | Challenges of Process Development And Scale Up of API |
W.H. Tseng, Ph. D. Vice President at Savior Life Corporation |
|
14:30~15:30 | Technology Platform for Nano Medicine Development |
Jassy Wang , Ph. D. Deputy General Director at Industrial Technology Research Institute |
|
15:30~15:50 | Coffee Break | ||
15:50~16:50 | CMC, toxicology and efficacy study development in Nanoparticle Drug Delivery System. |
Duncan Chen CEO at Original BioMedicals |
|
16:50~17:20 | Panel Discussion | 全體主講者暨主持人 |